Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Filana Therapeutics Beat Earnings?

Filana Therapeutics (FLNA) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Filana Therapeutics’s job postings, web traffic, and employee business outlook. See the full FLNA stock analysis or the earnings calendar for upcoming reports.

Filana Therapeutics Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue————————
Gross margin————————
Operating margin————————
Net income-28M-28M-23M-44M-11M-13M-10M-8.6M
Net margin————————
EPS————————

Filana Therapeutics Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Filana Therapeutics’s quarterly revenue moved from $0 to $0.

When Is Filana Therapeutics’s Next Earnings Date?

Filana Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the FLNA earnings calendar.

Frequently Asked Questions: Filana Therapeutics Earnings

Filana Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Filana Therapeutics reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the FLNA AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.